We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
-18.26%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$859M
AUM Growth
-$274M
Cap. Flow
+$11.4M
Cap. Flow %
1.32%
Top 10 Hldgs %
49.67%
Holding
76
New
1
Increased
28
Reduced
18
Closed
5

Top Buys

Rank Stock Value
1
NEO icon
NeoGenomics
NEO
+$18.2M
2
SIBN icon
SI-BONE Inc
SIBN
+$15.4M
3
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$13.1M
4
ATRC icon
AtriCure
ATRC
+$5.44M
5
AXGN icon
Axogen
AXGN
+$5.14M

Top Sells

Rank Stock Value
1
HALO icon
Halozyme
HALO
+$28.4M
2
XENT
Intersect ENT, Inc
XENT
+$19.6M
3
STRO icon
Sutro Biopharma
STRO
+$13.7M
4
KRYS icon
Krystal Biotech
KRYS
+$7.61M
5
BCYC
Bicycle Therapeutics
BCYC
+$3.92M

Sector Composition

Rank Sector Weight
1 Healthcare 86.58%
2 Communication Services 8.2%
3 Energy 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KIDS icon
26
OrthoPediatrics
KIDS
$519M
$13.6M 1.58%
314,724
+62,638
+25% +$2.87M
PHLT
27
DELISTED
Performant Healthcare Inc
PHLT
$13.2M 1.54%
5,019,777
-28,246
-0.6% -$70.1K
BCYC
28
Bicycle Therapeutics
BCYC
$269M
$11.8M 1.38%
704,282
-185,892
-21% -$3.92M
TPTX
29
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$10.6M 1.23%
140,801
-67,829
-33% -$3.01M
OPRX icon
30
OptimizeRx
OPRX
$114M
$9.88M 1.15%
360,761
+30,215
+9% +$895K
BVS icon
31
Bioventus
BVS
$892M
$9.2M 1.07%
1,348,460
+446,935
+50% +$4.56M
BMRN icon
32
BioMarin Pharmaceuticals
BMRN
$11.6B
$8.69M 1.01%
104,813
+11,731
+13% +$934K
PFE icon
33
Pfizer
PFE
$143B
$7.67M 0.89%
146,356
-879
-0.6% -$44.8K
CDXS icon
34
Codexis
CDXS
$151M
$7.17M 0.83%
685,213
-144,789
-17% -$1.82M
MXCT icon
35
MaxCyte
MXCT
$112M
$6.24M 0.73%
1,319,489
-1,917
-0.1% -$9.44K
PLRX icon
36
Pliant Therapeutics
PLRX
$64.4M
$6.16M 0.72%
769,370
+358,042
+87% +$2.29M
MIRM icon
37
Mirum Pharmaceuticals
MIRM
$6.46B
$5.4M 0.63%
277,674
+62,635
+29% +$1.48M
GMAB icon
38
Genmab
GMAB
$17.7B
$5.23M 0.61%
160,885
-1,028
-0.6% -$33.3K
SLP icon
39
Simulations Plus
SLP
$369M
$3.75M 0.44%
75,985
-468
-0.6% -$22.1K
ABCM
40
DELISTED
Abcam PLC
ABCM
$3.19M 0.37%
220,838
-2,548
-1% -$39.4K
NARI
41
DELISTED
Inari Medical, Inc. Common Stock
NARI
$3.06M 0.36%
45,029
-350
-0.8% -$25.2K
IWO icon
42
iShares Russell 2000 Growth ETF
IWO
$14.3B
$2.73M 0.32%
+13,242
New +$2.95M
LHCG
43
DELISTED
LHC Group LLC
LHCG
$2.4M 0.28%
15,392
-108
-0.7% -$17.8K
AKU
44
DELISTED
Akumin Inc
AKU
$2.26M 0.26%
3,764,264
+53,879
+1% +$48.2K
MIRO
45
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
$2.06M 0.24%
516,007
+3,700
+0.7% +$14.2K
SIEN
46
DELISTED
Sientra, Inc.
SIEN
$1.2M 0.14%
143,139
-35,797
-20% -$488K
ELV icon
47
Elevance Health
ELV
$81.5B
$600K 0.07%
1,244
– –
UTHR icon
48
United Therapeutics
UTHR
$25.8B
$581K 0.07%
2,466
– –
ABBV icon
49
AbbVie
ABBV
$443B
$573K 0.07%
3,740
– –
BMY icon
50
Bristol-Myers Squibb
BMY
$133B
$559K 0.07%
7,256
– –
1
2
3 4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, First Light Asset Management held 76 positions worth $859M, down 24% from $1.13B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

First Light Asset Management's Q2 2022 filing shows 1 new, 28 increased, 18 reduced and 5 closed positions. Its largest new stake was iShares Russell 2000 Growth ETF: 13,242 shares worth $2.73M. The largest sale was Halozyme, an estimated $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 84% a quarter earlier, followed by Communication Services and Energy.

  • First Light Asset Management's largest Q2 2022 buy was iShares Russell 2000 Growth ETF: 13,242 shares worth $2.73M.
  • First Light Asset Management added most to NeoGenomics in Q2 2022, an estimated $18.2M increase.
  • First Light Asset Management's biggest Q2 2022 reduction was Halozyme, cutting an estimated $28.4M.
  • First Light Asset Management fully exited Intersect ENT, Inc in Q2 2022, selling an estimated $19.6M.
  • First Light Asset Management's ten largest holdings make up 50% of its $859M portfolio in Q2 2022.
  • First Light Asset Management opened 1 new position and closed 5 in Q2 2022.
  • First Light Asset Management's portfolio value fell 24% quarter-over-quarter to $859M.

Based on First Light Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.